Clinical Trials Logo

Hypertension clinical trials

View clinical trials related to Hypertension.

Filter by:

NCT ID: NCT06403722 Completed - Clinical trials for Hypertension in Pregnancy

Perinatal Outcomes in Patients With Elevated sFlt-1/PlGF Ratio

Start date: November 15, 2023
Phase:
Study type: Observational

Retrospective cohort study that evaluated 190 subjects admitted with diagnosis of hypertensive disorder of pregnancy, between 24 and 36 6/7 weeks, with an sFlt-1/PlGF index greater than or equal to 110. Data were collected on their clinical course prior to termination of pregnancy, using the last reported sFlt-1/PlGF ratio value to classify the population into four cohorts: values between 110-205, between 206 and 654, between 655 and 999 and greater than 1000.

NCT ID: NCT06395194 Completed - Clinical trials for Essential Hypertension

Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension

VALUE
Start date: September 27, 1997
Phase: Phase 3
Study type: Interventional

The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial tested the hypothesis that for the same blood-pressure control, valsartan would reduce cardiac morbidity and mortality more than amlodipine in hypertensive patients at high cardiovascular risk. The present study investigates effects of valsartan and amlodipine on pre-specified secondary kidney outcomes.

NCT ID: NCT06393621 Completed - Prehypertension Clinical Trials

Investigate the Effectiveness of KEFPEP® on Regulating High Blood Pressure

Start date: July 26, 2018
Phase: N/A
Study type: Interventional

To assess the ability of KEFPEP® to reduce blood pressure

NCT ID: NCT06387927 Completed - Hypertension Clinical Trials

Effect of Home-exercise Programs Versus Supervised Core Stability Exercises on Hypertensive Patient With Low Back Pain

Start date: September 2, 2023
Phase: N/A
Study type: Interventional

Thirty male and female hypertension patients with chronic mechanical non-specific low back pain were included in this randomized controlled study conducted at the Ababa Private Physical Therapy Center in Beni-Seuf, Egypt. They were randomly assigned into two equal groups; the study group A control (n = 15) had a supervised conventional core stability, while the study group B (n = 15) received a home exercise program. In both groups' patients had evaluations before and after their six-week course of therapy. Modified-modified Schober test was used to assess the active back range of motion (ROM), Arabic version of Oswestry disability index (ODI) was utilized to evaluate functional disability, and visual analog scale (VAS) was used to measure pain.

NCT ID: NCT06359873 Completed - Atrial Fibrillation Clinical Trials

Left Atrial Enlargement: A Crucial Indicator for Identifying Atrial Fibrillation in Patients With Hypertension

Start date: May 1, 2022
Phase:
Study type: Observational

Based on the data of inpatients with hypertension and a cross-sectional study with a large sample size, this study aims to find the early warning value of the left anteroposterior atrial diameter for the possible occurrence of atrial fibrillation in patients with hypertension, and compare the advantages and disadvantages of the above two methods for the early warning of the risk of atrial fibrillation in patients with hypertension, so as to achieve the purpose of early identification of high-risk groups that may develop atrial fibrillation.

NCT ID: NCT06337734 Completed - Hypertension Clinical Trials

An Artificial Intelligence-Assisted Digital Health Lifestyle Intervention for Adults With Hypertension

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

This study evaluates the impact of a fully digital, autonomous, and artificial intelligence (AI)-driven lifestyle coaching program on managing blood pressure (BP) among adults diagnosed with hypertension. Participants received a BP monitor and a wearable activity tracker to facilitate data collection. This data, along with responses from a questionnaire mobile app, were analyzed by an automated analytics engine employing statistical and machine learning techniques. The program delivered tailored lifestyle coaching directly to participants through a mobile app, aiming for precise and effective BP management.

NCT ID: NCT06315764 Completed - Hypertension Clinical Trials

Effect of the Reflexology on Insomnia Severity Index in Hypertensive Patients

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

In Egypt, there is a dearth of understanding of the benefits of reflexology and aerobic exercise on hypertension patients' quality of life.

NCT ID: NCT06312111 Completed - Clinical trials for Pulmonary Arterial Hypertension

Physical Activity and Various Aspects of Quality of Life in Patients With Pulmonary Arterial Hypertension (Ph-PAH)

PhA-PAH
Start date: April 22, 2021
Phase: N/A
Study type: Interventional

Evaluate whether education, a simple doctor's recommendation to increase physical activity in inactive patients, and self-monitoring of physical activity using a pedometer were effective and beneficial for patients with pulmonary arterial hypertension (PAH)

NCT ID: NCT06307483 Completed - Hypertension Clinical Trials

Dose-effect Relationship of Tai Chi on Health Promotion in Different Age Groups

Start date: August 25, 2023
Phase:
Study type: Observational

The purpose of this study is to investigate the physical and mental health status of middle-aged and elderly people of different ages and practicing Tai chi for different periods of time, so as to provide a strong theoretical basis and practical guidance for delaying age-related aging and preventing and treating the occurrence and development of chronic diseases.

NCT ID: NCT06303830 Completed - Hypertension Clinical Trials

Bariatric Surgery and Cardiovascular Responses to Sodium Nitrate

Start date: April 16, 2019
Phase: N/A
Study type: Interventional

Inorganic nitrite and nitrate can be reduced to NO and NO-related species such as S-nitrosothiols via the nitrate-nitrite-NO pathway. This is due to the reduction of nitrate to nitrite by the action of bacteria in the mouth and the reduction of nitrite to NO depending on the acidic pH on the stomach or by enzymes with nitrite-reductase activity. The acidic environment of the stomach is very important to the formation of NO and S-nitrosothiols and several studies suggest that changes in gastric pH can affect this conversion. In this context, bariatric surgery, by altering the anatomy of the stomach and increasing gastric pH, can affect the nitrate-nitrite-NO pathway and change the antihypertensive and antioxidant effect of sodium nitrate.